Renowned molecular diagnostics provider CepheidCPHD recently entered into a non-exclusive distribution agreement with Henry Schein Medical, the Medical business of one of the leading healthcare ...

Recently, Cepheid ( CPHD) has received clearance from the US Food and Drug Administration (FDA) for its high-throughput automated molecular system GeneXpert Infinity-80. GeneXpert Infinity-80 is a ...

Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases OXFORD, United Kingdom and SUNNYVALE, Calif., ...

SpeeDx to bring first sample-to-answer Mycoplasma genitalium and macrolide resistance test to Europe SYDNEY--(BUSINESS WIRE)--SpeeDx Pty, Ltd. today announced the European launch of ResistancePlus® MG ...

SYDNEY--(BUSINESS WIRE)--SpeeDx Pty, Ltd. today announced ResistancePlus® MG FleXible for the Cepheid GeneXpert® System, detecting the sexually transmitted infection (STI) Mycoplasma genitalium (Mgen) ...

Cepheid, a leading molecular diagnostics company, and FIND, an international non-profit organisation, launched the GeneXpert Omni, the world's most portable molecular diagnostics system enabling ...

Cepheid just received CE-IVD mark for its Xpert TV molecular test for identifying Trichomoniasis infections in both men and women. The test will run on Cepheid's GeneXpert System, the world’s leading ...

Cepheid has announced the European release of the Xpert™ MRSA (Methicillin-resistant Staphylococcus aureus) test for clinical diagnostic use on the GeneXpert ® System. The MRSA test was released as a ...

SUNNYVALE, Calif. and BIRMINGHAM, Ala., June 27, 2022 /PRNewswire/ -- Cepheid and BioGX today announced a collaboration between the two companies to deliver a PCR test for Monkeypox that will run on ...

GeneXpert Anthrax tests combine sample preparation with real-time PCR (polymerase chain reaction) amplification and detection for fully automated DNA analysis. The system purifies, concentrates, ...